@article{f3a8b458e7c04db5bb3e107199473526,
title = "Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis",
author = "A. Blauvelt and K. Reich and Warren, {R. B.} and Szepietowski, {J. C.} and B. Sigurgeirsson and Tyring, {S. K.} and I. Messina and V. Bhosekar and J. Oliver and C. Papavassilis and J. Frueh and Langley, {R. G.B.}",
note = "Funding Information: The authors received writing and editorial support from Andrew Horgan, PhD (BioScience Communications, New York, NY), which was supported by Novartis.",
year = "2017",
month = sep,
doi = "10.1111/bjd.15656",
language = "English",
volume = "177",
pages = "879--881",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "3",
}